Efficacy and Safety of Subcutaneous Golimumab in Methotrexate-Naive Patients With Rheumatoid Arthritis: Five-Year Results of a Randomized Clinical Trial

Emery Paul; Fleischmann Roy M.; Strusberg Ingrid; Durez Patrick; Nash Peter; Amante Eric Jason B.; Churchill Melvin; Park Won; Pons-Estel Bernardo; Han Chenglong; Gathany Timothy A.; Xu Stephen; Zhou Yiying; Leu Jocelyn H.; Hsia Elizabeth C.

首页> 外文期刊>Arthritis care & research >Efficacy and Safety of Subcutaneous Golimumab in Methotrexate-Naive Patients With Rheumatoid Arthritis: Five-Year Results of a Randomized Clinical Trial

【24h】

Efficacy and Safety of Subcutaneous Golimumab in Methotrexate-Naive Patients With Rheumatoid Arthritis: Five-Year Results of a Randomized Clinical Trial

机译：甲氨蝶呤初治类风湿关节炎患者皮下戈利木单抗的疗效和安全性：一项随机临床试验的五年结果

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective. To evaluate the safety and efficacy of golimumab through 5 years in adults with active rheumatoid arthritis (RA) who had not previously received methotrexate (MTX).

机译：目的。评估戈利木单抗在未曾接受甲氨蝶呤（MTX）的活动性类风湿关节炎（RA）成人中治疗5年的安全性和有效性。

著录项

来源
《Arthritis care & research》 |2016年第6期|共9页
作者
Emery Paul; Fleischmann Roy M.; Strusberg Ingrid; Durez Patrick; Nash Peter; Amante Eric Jason B.; Churchill Melvin; Park Won; Pons-Estel Bernardo; Han Chenglong; Gathany Timothy A.; Xu Stephen; Zhou Yiying; Leu Jocelyn H.; Hsia Elizabeth C.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词

相似文献

外文文献
中文文献
专利

1. 单发肝细胞癌合并微血管侵犯患者根治性切除术后辅助经导管动脉化疗栓塞治疗的疗效和安全性:一项随机临床试验 [J] . Wei Wei, Lie Zheng, Min-Shan Chen, 癌症（英文版） . 2019,第003期
2. Efficacy and Safety of Subcutaneous Golimumab in Methotrexate-Naive Patients With Rheumatoid Arthritis: Five-Year Results of a Randomized Clinical Trial [J] . Emery Paul, Fleischmann Roy M., Strusberg Ingrid, Arthritis care & research . 2016,第6期

机译：甲氨蝶呤初治类风湿关节炎患者皮下戈利木单抗的疗效和安全性：一项随机临床试验的五年结果
3. Five-year Safety Data from 5 Clinical Trials of Subcutaneous Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis [J] . Kay Jonathan, Fleischmann Roy, Keystone Edward, The Journal of rheumatology . 2016,第12期

机译：风湿性关节炎，银屑病关节炎和强直性脊柱炎患者皮下Golimumab的5个临床试验的5年安全性数据
4. Efficacy and safety results from a Phase 3, randomized, placebo-controlled trial of subcutaneous golimumab in Chinese patients with active rheumatoid arthritis despite methotrexate therapy [J] . Li Zhanguo, Zhang Fengchun, Kay Jonathan, International journal of rheumatic diseases . 2016,第11期

机译：尽管甲氨蝶呤治疗对患有活动性类风湿性关节炎的中国患者进行皮下戈利木单抗的三期随机安慰剂对照试验的有效性和安全性
5. Immunogenic HLA-DR-presented-peptides Identified from Clinical Samples of Synovial Tissue/Fluid and Peripheral Blood from Patients with Rheumatoid Arthritis or Lyme Arthritis [C] . Qi Wang, Elise E. Drouin, Chunxiang Yao, ASMS Conference on Mass Spectrometry and Allied Topics . 2016

机译：免疫原性HLA-DR呈递肽，从类风湿性关节炎或莱姆关节炎患者的滑膜组织/液体和外周血的临床样本中鉴定出来
6. Clinical research on the preventive efficacy of sulfasalazine against Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis [D] . 布川貴博 2019

机译：柳氮磺胺吡啶对类风湿关节炎肺炎克氏杆菌的预防作用的临床研究
7. Clinical efficacy radiographic progression and safety through 156 weeks of therapy with subcutaneous golimumab in combination with methotrexate in Japanese patients with active rheumatoid arthritis despite prior methotrexate therapy: final results of the randomized GO-FORTH trial [O] . Yoshiya Tanaka, Masayoshi Harigai, Tsutomu Takeuchi, -1

机译：尽管有甲氨蝶呤治疗但活动性类风湿性关节炎日本患者经皮下Golimumab联合甲氨蝶呤治疗156周后的临床疗效影像学进展和安全性：GO-FORTH随机试验的最终结果
8. Efficacy and Safety of Subcutaneous Golimumab in Methotrexate-Naive Patients With Rheumatoid Arthritis: Five-Year Results of a Randomized Clinical Trial [O] . Emery P, Fleischmann RM, Strusberg I, 2016

机译：皮下Golimumab在甲氨蝶呤治疗类风湿性关节炎患者中的疗效和安全性：随机临床试验的五年结果

Efficacy and Safety of Subcutaneous Golimumab in Methotrexate-Naive Patients With Rheumatoid Arthritis: Five-Year Results of a Randomized Clinical Trial

摘要

著录项

相似文献

相关主题

期刊订阅